Curevac N V Net Income per Employee (CVAC), current and historic results, rankings and more, Quarterly Fundamentals - CSIMarket
CSIMarket Company Name, Ticker, Industry, else..
 


• Sales per Employee
• Income per Employee
• Inventory Turnover
• Asset Turnover
• Receivables Turnover
Curevac N v   (NASDAQ: CVAC)
 

Curevac N V Net Income per Employee

CVAC's Quarterly Results, Trends, Rankings, Statistics
Curevac N V 's Income per employee grew in the fourth quarter 2024 on a trailing twelve month basis to $ 1,076,660, the income was higher than average, indicating higher productivity of the company's employees.
The Healthcare sector has seen employees of 20 other companies achieving higher income per employee. While income per employee total ranking has improved so far to 328, from total ranking in previous quarter at 3893.


What is Income per Employee Ratio?





Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

CVAC Net Income per Employee (Dec 31 2024)
IV. Quarter		 0
III. Quarter		 0
II. Quarter		 0
I. Quarter		 (Dec 31 2023)
IV. Quarter
Y / Y Net Income Change - - - - -
Net Income per Employee (TTM) $ 1,076,660 -201,814 -1,348,802 -1,336,104 -1,295,619
CVAC's Total Ranking # 328 # 3893 # # #
Seq. Net Income Change -51.09 % - - - -

CVAC Company Profile >> Back to CVAC Efficiency Comparisons >> Compare CVAC Net Income per Employee to its Competitors

CVAC Net Income per Employee Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry # 21
Healthcare Sector # 36
Overall Market # 328

Net Income per Employee Statistics
High Average Low
$ 490,941 $ -229,149 $ -787,533
(Dec 31 2024)   (Dec 31 2023)







Companies with similar Income per Employee for 12 month ending Dec 31 2024, within Healthcare Sector Income per Employee Income 12 month ending Dec 31 2024Number of Employees Dec 31 2024
Purple Biotech Ltd  1,819,750.00 $ 7.279  Million 4 
Alumis inc   1,540,196.43 $ 345.004  Million 224 
Glucotrack Inc   1,506,466.67 $ 22.597  Million 15 
Semler Scientific inc   1,319,322.58 $ 40.899  Million 31 
Agios Pharmaceuticals Inc   1,247,638.89 $ 673.725  Million 540 
Siga Technologies Inc  1,208,453.39 $ 59.214  Million 49 
Chemomab Therapeutics Ltd   1,162,083.33 $ 13.945  Million 12 
Tenax Therapeutics Inc   1,100,125.00 $ 17.602  Million 16 
Halozyme Therapeutics Inc   1,049,860.52 $ 444.091  Million 423 
Exelixis Inc   1,048,741.94 $ 1,202.907  Million 1,147 
Scienture Holdings Inc   1,007,310.89 $ 9.066  Million 9 
Catalyst Pharmaceuticals Inc   900,489.01 $ 163.889  Million 182 
Biomx Inc  886,350.00 $ 17.727  Million 20 
Entrada Therapeutics Inc   869,151.32 $ 132.111  Million 152 
Prestige Consumer Healthcare Inc   862,257.89 $ 491.487  Million 570 
Third Harmonic Bio Inc   857,905.66 $ 45.469  Million 53 
United Therapeutics Corporation  853,642.86 $ 1,195.100  Million 1,400 
Engene Therapeutics Inc   842,036.59 $ 69.047  Million 82 
Argenx Se  725,644.60 $ 833.040  Million 1,148 
Pavmed Inc   693,341.46 $ 28.427  Million 41 
Orgenesis Inc   636,532.47 $ 49.013  Million 77 


Date modified: 2026-08-30T09:00:32+00:00




Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.